Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
NCT05501483
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Pioglitazone 45 mg
DRUG:
Empagliflozin 25 MG
DRUG:
Semaglutide 7 MG
Sponsor
Karolinska Institutet
Collaborators
[object Object]